These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 14660569)
1. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. Tronchère H; Laporte J; Pendaries C; Chaussade C; Liaubet L; Pirola L; Mandel JL; Payrastre B J Biol Chem; 2004 Feb; 279(8):7304-12. PubMed ID: 14660569 [TBL] [Abstract][Full Text] [Related]
2. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Chaussade C; Pirola L; Bonnafous S; Blondeau F; Brenz-Verca S; Tronchère H; Portis F; Rusconi S; Payrastre B; Laporte J; Van Obberghen E Mol Endocrinol; 2003 Dec; 17(12):2448-60. PubMed ID: 14500759 [TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Schaletzky J; Dove SK; Short B; Lorenzo O; Clague MJ; Barr FA Curr Biol; 2003 Mar; 13(6):504-9. PubMed ID: 12646134 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Laporte J; Kress W; Mandel JL Ann Neurol; 2001 Jul; 50(1):42-6. PubMed ID: 11456308 [TBL] [Abstract][Full Text] [Related]
5. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Tosch V; Rohde HM; Tronchère H; Zanoteli E; Monroy N; Kretz C; Dondaine N; Payrastre B; Mandel JL; Laporte J Hum Mol Genet; 2006 Nov; 15(21):3098-106. PubMed ID: 17008356 [TBL] [Abstract][Full Text] [Related]
6. A phosphoinositide conversion mechanism for exit from endosomes. Ketel K; Krauss M; Nicot AS; Puchkov D; Wieffer M; Müller R; Subramanian D; Schultz C; Laporte J; Haucke V Nature; 2016 Jan; 529(7586):408-12. PubMed ID: 26760201 [TBL] [Abstract][Full Text] [Related]
7. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. Kim SA; Taylor GS; Torgersen KM; Dixon JE J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541 [TBL] [Abstract][Full Text] [Related]
8. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Taylor GS; Maehama T; Dixon JE Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8910-5. PubMed ID: 10900271 [TBL] [Abstract][Full Text] [Related]
9. The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. Ungewickell A; Hugge C; Kisseleva M; Chang SC; Zou J; Feng Y; Galyov EE; Wilson M; Majerus PW Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18854-9. PubMed ID: 16365287 [TBL] [Abstract][Full Text] [Related]
16. Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin. Tronchère H; Buj-Bello A; Mandel JL; Payrastre B Cell Mol Life Sci; 2003 Oct; 60(10):2084-99. PubMed ID: 14618257 [TBL] [Abstract][Full Text] [Related]
17. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590 [TBL] [Abstract][Full Text] [Related]